0,650  0,027  Antineoplastic (breast cancer)
0,635  0,013  Antineoplastic (ovarian cancer)
0,642  0,043  Antiinflammatory
0,605  0,031  Transcription factor NF kappa B inhibitor
0,573  0,014  Antineoplastic (pancreatic cancer)
0,573  0,015  Antiprotozoal (Plasmodium)
0,557  0,019  Bone diseases treatment
0,553  0,025  Antiprotozoal
0,575  0,055  Apoptosis agonist
0,527  0,017  Antiosteoporotic
0,504  0,016  Nitric oxide antagonist
0,482  0,023  AR expression inhibitor
0,480  0,025  Antineoplastic (cervical cancer)
0,462  0,023  NOS2 expression inhibitor
0,442  0,010  Abortion inducer
0,462  0,048  CYP3A4 substrate
0,419  0,009  Prostate disorders treatment
0,464  0,057  TNF expression inhibitor
0,414  0,013  Contraceptive
0,445  0,044  Antineoplastic (colorectal cancer)
0,441  0,042  Antineoplastic (colon cancer)
0,416  0,020  Dependence treatment
0,422  0,033  NOS3 expression inhibitor
0,437  0,053  Antileukemic
0,393  0,011  Antipruritic, non-allergic
0,390  0,009  Lipocortins synthesis antagonist
0,406  0,027  Chemopreventive
0,405  0,028  Cardiotonic
0,389  0,013  Prostatic (benign) hyperplasia treatment
0,390  0,020  Sodium/bile acid cotransporter inhibitor
0,387  0,018  Antihelmintic
0,428  0,059  Antineoplastic (lung cancer)
0,419  0,050  Stroke treatment
0,380  0,013  Antiviral (Influenza)
0,402  0,039  ICAM1 expression inhibitor
0,420  0,068  Antibacterial
0,378  0,028  Antiparasitic
0,378  0,040  Antineoplastic (glioma)
0,369  0,035  Cardiovascular analeptic
0,350  0,023  UGT1A1 substrate
0,316  0,009  UGT2B9 substrate
0,347  0,042  Antiprotozoal (Leishmania)
0,355  0,064  Prostate cancer treatment
0,349  0,060  Hepatic disorders treatment
0,350  0,064  Cholesterol antagonist
0,331  0,048  Sensitization
0,304  0,026  UGT2B7 substrate
0,329  0,055  Antihypercholesterolemic
0,327  0,057  CYP2C19 substrate
0,387  0,119  Caspase 9 stimulant
0,308  0,044  Antineoplastic (glioblastoma multiforme)
0,280  0,024  Antiacne
0,318  0,064  Antineoplastic (melanoma)
0,262  0,008  Estrogen antagonist
0,341  0,092  Antiobesity
0,306  0,060  Antidiabetic (type 2)
0,305  0,070  Metabolic disease treatment
0,251  0,020  Toxic, respiratory center
0,269  0,038  Hepatoprotectant
0,234  0,005  Pregnane X receptor agonist
0,292  0,065  UGT2B4 substrate
0,284  0,058  Proliferative diseases treatment
0,231  0,008  Estrogen receptor beta antagonist
0,282  0,060  Antineoplastic (renal cancer)
0,299  0,077  Antineoplastic (endocrine cancer)
0,272  0,059  Antineoplastic (lymphoma)
0,253  0,048  UDP-glucuronosyltransferase substrate
0,288  0,089  Antineoplastic (brain cancer)
0,201  0,004  Opioid kappa receptor agonist
0,310  0,114  Antipruritic, allergic
0,258  0,062  Antineoplastic (sarcoma)
0,197  0,004  Ca(v)3.1 blocker
0,282  0,089  Antifungal
0,226  0,033  Interferon gamma antagonist
0,198  0,008  Estrogen agonist
0,212  0,023  Arachidonic acid antagonist
0,200  0,013  Dementia treatment
0,193  0,008  Postmenopausal disorders treatment
0,194  0,011  Opioid kappa receptor antagonist
0,196  0,013  Vascular dementia treatment
0,179  0,005  CC chemokine 6 receptor antagonist
0,247  0,074  Acute neurologic disorders treatment
0,186  0,015  Androgen antagonist
0,198  0,028  Neurotrophic factor
0,201  0,033  Acetylcholinesterase inhibitor
0,212  0,045  UGT1A3 substrate
0,208  0,043  Cholinergic
0,174  0,010  SULT1E1 substrate
0,222  0,060  Platelet adhesion inhibitor
0,232  0,070  Antihypotensive
0,243  0,090  Chemoprotective
0,163  0,012  Anabolic
0,164  0,014  Contraceptive male
0,170  0,023  Constipation treatment
0,192  0,045  Antiparkinsonian, tremor relieving
0,273  0,129  CYP2C9 substrate
0,246  0,104  Hypoxia-inducible factor 1 alpha inhibitor
0,185  0,043  Antidiarrheal
0,217  0,077  RNA-directed DNA polymerase inhibitor
0,150  0,012  Estrogen receptor alpha antagonist
0,143  0,007  Na+ K+ transporting ATPase inhibitor
0,147  0,013  Aromatase inhibitor
0,168  0,038  Antifungal (Cryptococcus)
0,182  0,054  UGT2B10 substrate
0,155  0,030  Antineoplastic antibiotic
0,212  0,089  Teratogen
0,240  0,120  CTGF expression inhibitor
0,152  0,032  Contraceptive female
0,237  0,118  Antimycobacterial
0,173  0,055  UGT2B15 substrate
0,124  0,009  Estrogen receptor beta agonist
0,246  0,132  Apoptosis antagonist
0,128  0,017  Antiprotozoal activity enhancer
0,189  0,085  Pneumotoxic
0,156  0,052  Psychosexual dysfunction treatment
0,108  0,005  Postcoital contraceptive
0,174  0,071  UGT1A4 substrate
0,141  0,039  Alcohol dehydrogenase substrate
0,195  0,093  Embryotoxic
0,203  0,102  Vasodilator
0,195  0,093  Cardiodepressant
0,114  0,015  Narcotic antagonist
0,174  0,076  Antirickettsial
0,162  0,065  Antiviral (Influenza A)
0,125  0,030  UGT2B11 substrate
0,168  0,075  Antipruritic
0,099  0,009  Progesterone antagonist
0,099  0,009  Estrogen receptor alpha agonist
0,191  0,102  UGT1A6 substrate
0,230  0,141  Antineoplastic (osteosarcoma)
0,211  0,124  Respiratory analeptic
0,095  0,008  Heme oxygenase stimulant
0,173  0,086  P-glycoprotein inhibitor
0,121  0,036  Opioid antagonist
0,222  0,140  Caspase 3 stimulant
0,213  0,131  Antineoplastic (multiple myeloma)
0,192  0,112  Antineoplastic (non-small cell lung cancer)
0,211  0,132  CYP2D6 substrate
0,114  0,035  ABCA1 expression enhancer
0,213  0,137  CYP1A2 substrate
0,125  0,055  Microtubule formation inhibitor
0,165  0,095  Cytotoxic
0,188  0,119  Heart failure treatment
0,081  0,013  Lipocortins synthesis agonist
0,133  0,065  Antihemorrhagic
0,102  0,037  Transcription factor NF kappa B stimulant
0,088  0,029  Glycine receptor agonist
0,169  0,111  Neurotrophic factor enhancer
0,066  0,009  Glucocorticoid antagonist
0,081  0,024  SULT2A1 substrate
0,138  0,084  Adenylate cyclase stimulant
0,224  0,172  Immunosuppressant
0,150  0,099  Carcinogenic
0,113  0,063  Endometrios treatment
0,098  0,048  Antineoplastic alkaloid
0,087  0,037  Opioid mu receptor antagonist
0,081  0,031  Anticholelithogenic
0,067  0,017  Potassium channel Kv1.3 blocker
0,060  0,011  RNA-directed RNA polymerase stimulant
0,071  0,023  Opioid agonist
0,257  0,209  Alzheimer's disease treatment
0,115  0,071  Adenylate cyclase inhibitor
0,123  0,079  Anesthetic
0,046  0,003  Excitatory amino acid transporter 1 inhibitor
0,049  0,008  Protein 30S ribosomal subunit inhibitor
0,187  0,147  UGT1A9 substrate
0,153  0,114  Psychostimulant
0,185  0,147  Cardioprotectant
0,127  0,088  Antimutagenic
0,156  0,119  Angiogenesis stimulant
0,114  0,077  Growth stimulant
0,110  0,075  Cholesterol synthesis inhibitor
0,075  0,041  Premenstrual syndrome treatment
0,092  0,059  Paget's disease treatment
0,136  0,104  Melanin inhibitor
0,036  0,006  Progesterone agonist
0,155  0,125  CYP2B6 inhibitor
0,078  0,050  Analgesic, opioid
0,066  0,037  Antimycoplasmal
0,099  0,071  Toll-Like receptor 4 antagonist
0,052  0,025  Microtubule stabilization
0,053  0,026  5 Hydroxytryptamine 2C agonist
0,064  0,037  Androgen agonist
0,171  0,145  Hypoglycemic
0,118  0,092  Antifungal enhancer
0,169  0,144  Antioxidant
0,097  0,075  UGT2B1 substrate
0,024  0,003  Antibiotic Tetracycline-like
0,173  0,152  Analeptic
0,038  0,018  Tubulin agonist
0,072  0,053  CDC25A inhibitor
0,165  0,147  Vascular (periferal) disease treatment
0,085  0,067  Actinic keratosis treatment
0,096  0,079  Choleretic
0,113  0,096  Cocaine dependence treatment
0,110  0,093  Antihyperlipoproteinemic
0,164  0,148  Antineoplastic (liver cancer)
0,115  0,098  Protein kinase stimulant
0,039  0,023  Glucose-6-phosphate dehydrogenase inhibitor
0,045  0,032  Parathyroid hormone antagonist
0,023  0,013  Corticosteroid-like
0,024  0,014  Estrone sulfatase inhibitor
0,075  0,065  Glycine receptor antagonist
0,017  0,008  Glucocorticoid agonist
0,027  0,019  Retinoid X gamma receptor antagonist
0,027  0,020  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,047  0,043  Protein 50S ribosomal subunit inhibitor
0,018  0,015  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,019  0,016  Retinoic acid alpha receptor antagonist
0,012  0,010  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,121  0,120  Muscle relaxant
0,062  0,061  Hypercalcemia treatment
0,183  0,183  Immunomodulator

